| Literature DB >> 35473594 |
Amanda Bates1, Susan Furber2,3,4, Cathie Sherrington5,6, Paul van den Dolder7, Karen Ginn8, Adrian Bauman6, Kirsten Howard6, Michelle Kershaw2, Lisa Franco2, Cathy Chittenden9, Anne Tiedemann5,6.
Abstract
BACKGROUND: Falls are a significant public health issue. There is strong evidence that exercise can prevent falls and the most effective programs are those that primarily involve balance and functional exercises, however uptake of such programs is low. Exercise prescribed during home visits by health professionals can prevent falls however this strategy would be costly to deliver at scale. We developed a new approach to teach home exercise through group-based workshops delivered by physiotherapists. The primary aim was to determine the effect of this approach on the rate of falls among older community-dwelling people over 12 months. Secondary outcomes included the proportion of people falling, fear of falling, physical activity, lower limb strength, balance and quality of life.Entities:
Keywords: Accidental falls; Aged; Exercise; Falls prevention; Randomised controlled trial
Mesh:
Year: 2022 PMID: 35473594 PMCID: PMC9040211 DOI: 10.1186/s12877-022-03050-2
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Intervention description using the Template for Intervention Description and Replication (TIDieR) checklist
| Checklist item | |
|---|---|
| 1. Brief name | Balance Exercise Strength Training (BEST) at Home (lower limb) trial |
| 2. Why | Falls are a major and increasing public health issue. More than 25% of people 65 years and over fall at least once each year. Balance and strength training has been shown to reduce the risk of falling in older people. |
| 3. What materials | Participants in the intervention group received: - an exercise program designed to improve balance and strength in the lower limbs (including exercise instruction, printed manual and weights); - a booklet on preventing falls titled ‘Staying active and on your feet’ Participants in the control group received: - an exercise program designed to improve upper limb strength and mobility (including exercise instruction, printed manual, weights and exercise band) |
| 4. What procedures | Both the intervention and control groups received three group-based exercise instruction sessions and three measurement sessions. |
| 5. Who provided | Physiotherapists delivered the exercise instruction. Physiotherapists and exercise physiologists conducted the measurements. |
| 6. How | The exercise instruction was delivered face to face in small groups of approximately 10 participants. |
| 7. Where | In the community of the Illawarra and Shoalhaven regions, NSW, Australia. |
| 8. When and how much | Exercise instruction sessions were held in weeks 1, 4 and 12 (1 h duration). Participants were asked to perform the exercises three times per week for 12 months. The first measurement session occurred at baseline before the participant was randomised. The second and third measurement sessions were held at 12 weeks and 6 months. Final questionnaires were posted to participants at 12 months. |
| 9. Tailoring | Exercises were tailored by the physiotherapist for each participant, to meet their level of ability. |
| 10. Modifications | No modifications were made. |
| 11. How well (planned) | Adherence to the exercise program was assessed by self-reported exercise sessions, which were marked on calendars (and returned monthly) |
| 12. How well (actual) | Participants were asked to perform the exercises 3 times per week. Participants in the intervention group completed an average of 94 sessions over the 12 month period (less than twice per week). Participants in the control group completed an average of 104 sessions over the 12 month period (twice per week). |
Fig. 1Design and flow of participants through the trial. aFalls were measured monthly. bThe two people who died in the intervention group had completed monthly calendars and their data was included in the analysis (n = 290)
Characteristics of participants at baseline
| Characteristics | Intervention | Control | All |
|---|---|---|---|
| Age (years), mean (SD) | 72.9 (6.2) | 73.2 (5.8) | 73.1 (6.0) |
| Female: | 196 (63.8) | 197 (63.6) | 393 (63.7) |
| Lives alone: | 89 (29.0) | 97 (31.3) | 186 (30.2) |
| Fallen in the past 12 months: | 80 (26.1) | 86 (27.7) | 166 (26.9) |
| Self-rated balance fair/poor: | 99 (32.6) | 96 (31.2) | 195 (31.9) |
| Self-rated fear of falling ≥ moderate: | 79 (25.7) | 72 (23.4) | 151 (24.6) |
| Total medications (n), mean (SD) | 3.0 (2.6) | 3.3 (2.7) | 3.1 (2.7) |
| Medical conditions (0–17)a, mean (SD) | 2.8 (1.9) | 2.8 (2.0) | 2.8 (1.9) |
| Arthritis: | 173 (58.3) | 181 (58.6) | 354 (58.4) |
| Osteoporosis: | 66 (21.7) | 57 (18.6) | 123 (20.1) |
| Diabetes: | 26 (8.5) | 32 (10.4) | 58 (9.5) |
| Depression: | 51 (16.8) | 48 (15.8) | 99 (16.3) |
| Self-report physical activity, hours/weekb: mean (SD) | 33.4 (19.1) | 34.3 (19.2) | 33.9 (19.1) |
| SF12v2: physical composite score | 48.0 (7.7) | 47.8 (7.4) | 47.9 (7.6) |
| SF12v2: mental composite score | 53.4 (5.7) | 53.6 (5.4) | 53.5 (5.6) |
| Short FES-I, mean (SD) | 9.7 (3.3) | 9.4 (2.9) | 9.6 (3.1) |
| Average daily step count, steps, mean (SD) | 5725.9 (2424.6) | 5539.6 (2394.5) | 5634.2 (2409.5) |
| MVPA, minutes/day, mean (SD) | 18.9 (17.4) | 17.2 (16.8) | 18.0 (17.1) |
Abbreviations: FES-I Falls Efficacy Scale-International, MVPA moderate vigorous physical activity
aPossible medical conditions included: arthritis, osteoporosis, asthma, chronic obstructive pulmonary disease, angina, heart disease, heart attack, neurological disease, stroke/transient ischaemic attack, peripheral vascular disease, diabetes mellitus, upper gastrointestinal disease, depression, anxiety/panic disorder, visual impairment, hearing impairment, degenerative disc disease
bMeasured using the Incidental and Planned Exercise Questionnaire (IPEQ)
Number of participants falling and total number of falls during 12 month follow up
| Falls | All ( | Intervention ( | Control ( | Unadjusted IRR* (95% CI) |
|---|---|---|---|---|
| Number of falls, n | 267 | 138 | 129 | 0.91 (0.64 to 1.29), |
| Falls per participant, mean (SD), median (min-max) | 0.46 (1.03), 0 (0–12) | 0.48 (1.14), 0 (0–12) | 0.45 (0.91), 0 (0–5) | |
| Frequency of falls, n (%) | ||||
| 0 | 422 (72.9) | 211 (72.8) | 211 (73) | |
| 1 | 102 (17.6) | 51 (17.6) | 51 (17.6) | |
| 2 | 27 (4.7) | 16 (5.5) | 11 (3.8) | |
| 3 | 14 (2.4) | 5 (1.7) | 9 (3.1) | |
| ≥ 4 | 14 (2.4) | 7 (2.4) | 7 (2.4) | |
| 1+ falls | 157 (27.1) | 79 (27.2) | 78 (27) | 0.99 (0.76 to 1.29), |
| Follow up, days, mean (SD) | 311.8 (103.6) | 306.6 (105.7) | 317.1 (101.4) | |
| Falls indoors, n (%) | 90 (33.7) | 50 (36.2) | 40 (31) | |
| Falls outdoors, n (%) | 177 (66.3) | 88 (63.8) | 89 (69) | |
| Falls with fractures, n (%) | 16 (6) | 12 (8.7) | 4 (3.1) | |
| Falls requiring hospital admission, n (%) | 10 (3.7) | 5 (3.6) | 5 (3.9) | |
aBetween-group difference from negative binomial regression models comparing rates between groups adjusted for exposure: days of follow-up
bBetween-group difference from Poisson regression models comparing proportions between groups
*IRR Incidence rate ratio
**38 participants with no calendar data removed for analysis
Intervention effects on secondary outcomes
| Outcome measure | Intervention Mean (SD), | Control Mean (SD), | Mean difference (95% CI) | |
|---|---|---|---|---|
| Baseline | 9.7 (3.3) | 9.4 (2.9) n = 309 | ||
| 3 months | 9.1 (2.7) | 9.2 (2.7) | 0.50 (0.2–0.8) | 0.004* |
| 6 months | 9.2 (2.8) | 9.3 (2.9) | 0.39 (0.001–0.8) | 0.049* |
| 12 months | 9.1 (2.7) | 9.4 (2.9) | 0.46 (0.006–0.9) | 0.047* |
| Baseline | 48.0 (7.7) | 47.8 (7.4) | ||
| 3 months | 48.5 (7.6) | 48.1 (7.0) | −0.28 (−1.2–0.6) | 0.534 |
| 6 months | 48.0 (8.2) | 47.7 (7.8) | 0.26 (− 0.8–1.3) | 0.633 |
| 12 months | 48.5 (7.6) | 47.2 (8.7) | −1.1 (−2.3–0.008) | 0.052 |
| Baseline | 53.4 (5.7) | 53.6 (5.4) | ||
| 3 months | 54.1 (5.6) | 54.4 (5.3) | −0.1 (−1.1–0.8) | 0.808 |
| 6 months | 54.2 (5.3) | 54.1 (5.1) | −0.7 (−1.6–0.3) | 0.185 |
| 12 months | 54.4 (5.0) | 54.2 (4.8) | −0.1 (−1.1–0.8) | 0.824 |
| Baseline | 239.4 (110.6) | 229.7 (103.4) | ||
| 6 months | 245.5 (111.0) | 238.4 (112.9) | 0.4 (−14.1–14.8) | 0.960 |
| 12 months | 248.6 (111.0) | 245.5 (119.1) | 3.2 (−10.7–17.0) | 0.653 |
| Baseline | 5726 (2425) | 5540 (2394) | ||
| 6 months | 5957 (2653) | 5689 (2337) | −105 (− 429–219) | 0.525 |
| 12 months | 5958 (2532) | 5916 (2638) | 90 (−223–402) | 0.572 |
| Baseline | 18.9 (17.4) | 17.2 (16.8) | ||
| 6 months | 20.0 (18.1) | 17.6 (17.1) | −0.4 (−3.1–2.3) | 0.775 |
| 12 months | 19.8 (18.0) | 19.0 (18.6) | 0.3 (−2.1–2.8) | 0.785 |
| Baseline | 33.4 (19.1) | 34.3 (19.2) | ||
| 3 months | 33.4 (19.4) | 33.1 (18.1) | −1.1 (−3.6–1.5) | 0.412 |
| 6 months | 31.7 (17.3) | 33.0 (17.6) | 0.9 (−1.7–3.5) | 0.494 |
| 12 months | 31.3 (16.7) | 32.5 (17.6) | 0.9 (−1.7–3.6) | 0.491 |
| Baseline | 2.3 (3.8) | 2.2 (3.4) | ||
| 3 months | 2.8 (3.8) | 2.7 (3.1) | −0.2 (− 0.8–0.5) | 0.575 |
| 6 months | 2.7 (3.6) | 2.4 (2.9) | −0.04 (− 0.7–0.6) | 0.895 |
| 12 months | 2.1 (3.1) | 2.1 (3.5) | 0.2 (−0.4–0.9) | 0.514 |
| Baseline | 4.7 (5.6) | 4.6 (4.8) | ||
| 3 months | 5.3 (6.7) | 5.0 (4.7) | −0.2 (−1.2–0.8) | 0.702 |
| 6 months | 4.5 (4.2) | 4.8 (5.1) | 0.4 (−0.5–1.3) | 0.350 |
| 12 months | 5.1 (5.6) | 5.0 (6.1) | −0.03 (−1.1–1.0) | 0.951 |
| Baseline | 28.4 (18.2) | 29.3 (17.7) | ||
| 3 months | 27.7 (17.4) | 27.4 (16.6) | −0.8 (−3.1–1.6) | 0.519 |
| 6 months | 26.2 (16.6) | 28.2 (16.9) | 1.5 (−1.0–4.0) | 0.245 |
| 12 months | 25.9 (16.0) | 27.3 (16.2) | 0.87 (−1.6–3.3) | 0.487 |
| Baseline | 28.7 (5.2) | 28.4 (5.1) | ||
| 3 months | 28.1 (5.1) | 27.9 (4.8) | 0.15 (−0.05–0.4) | 0.132 |
| 6 months | 28.3 (5.0) | 28.1 (5.0) | −0.07 (− 0.3–0.1) | 0.525 |
| Baseline | 10.9 (1.5) | 10.8 (1.5) | ||
| 3 months | 11.1 (1.4) | 10.9 (1.3) | −0.06 (−0.3–0.1) | 0.537 |
| 6 months | 11.2 (1.4) | 11.3 (1.1) | 0.17 (−0.04–0.39) | 0.108 |
| Baseline | 2.52 (0.22) | 2.50 (0.23) | ||
| 3 months | 2.55 (0.23) | 2.53 (0.19) | −0.01 (−0.04–0.02) | 0.522 |
| 6 months | 2.56 (0.24) | 2.57 (0.17) | 0.03 (−0.002–0.06) | 0.070 |
| Baseline | 11.8 (3.5) | 12.0 (3.4) | ||
| 3 months | 11.0 (3.6) | 11.4 (3.4) | 0.15 (−0.35–0.66) | 0.548 |
| 6 months | 10.4 (3.6) | 11.0 (4.2) | 0.12 (−0.48–0.73) | 0.688 |
| Baseline | 2.8 (0.7) | 2.9 (0.8) | ||
| 3 months | 2.6 (0.7) | 2.8 (0.6) | 0.09 (0.003–0.19) | 0.043* |
| 6 months | 2.7 (0.6) | 2.8 (0.6) | −0.01 (−0.1–0.08) | 0.819 |
| Baseline | 29.0 (2.9) | 28.7 (3.5) | ||
| 3 months | 29.3 (2.3) | 28.8 (2.9) | −0.19 (−0.71–0.32) | 0.461 |
| 6 months | 29.3 (2.8) | 29.5 (1.7) | 0.51 (−0.0002–1.0) | 0.050 |
| Baseline | 8.4 (2.7) | 8.3 (2.8) | ||
| 3 months | 9.0 (2.3) | 8.7 (2.3) | −0.32 (−0.86–0.22) | 0.244 |
| 6 months | 9.2 (2.0) | 8.9 (2.3) | −0.21 (− 0.77–0.35) | 0.463 |
| Baseline | 8.3 (2.5) | 8.4 (2.1) | ||
| 3 months | 7.7 (2.4) | 8.1 (2.1) | 0.26 (−0.06–0.58) | 0.112 |
| 6 months | 7.3 (2.1) | 7.7 (2.3) | 0.23 (−0.11–0.57) | 0.189 |
| Baseline | 16.1 (7.7) | 14.6 (6.7) | ||
| 3 months | 17.4 (7.5) | 16.5 (6.6) | −0.55 (−1.72–0.63) | 0.361 |
| 6 months | 17.6 (7.8) | 16.2 (7.6) | −0.60 (−1.86–0.65) | 0.344 |
| Baseline | 15.4 (7.4) | 14.1 (6.8) | ||
| 3 months | 16.9 (7.1) | 15.8 (7.0) | −0.85 (−2.04–0.34) | 0.160 |
| 6 months | 16.6 (7.1) | 15.2 (6.6) | −1.05 (−2.20–0.10) | 0.072 |
aHigher scores reflect better performance
bLower scores reflect better performance
cSkewed distribution
dSelf-report measure using the Incidental and Planned Exercise Questionnaire (IPEQ)
*Significant outcome